FDA Authorizes Antibody Cocktail as COVID-19 Prevention Treatment

While the product remains authorized for treating confirmed COVID-19 patients over age 12 who are at high risk of severe illness, the agency said the drug combo can now be given to high-risk groups as a measure after exposure to prevent progression of the disease.

Read about it... Perhaps now doctors will start prescribing medicine that will save lives in the early stages of Covid..